Related Experiment Videos
Optimising nutrition for older people with dementia
1St Nicholas Hospital, Newcastle upon Tyne. delwyn@cole1228.freeserve.co.uk
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|March 2, 2012
Summary
Maintaining adequate nutrition in older adults with dementia is challenging. Interventions show promise, but staff training and vigilance are crucial for improving nutritional intake in dementia patients.
Area of Science:
- Gerontology
- Nutritional Science
- Dementia Care
Background:
- Adequate nutritional intake is a significant challenge for older adults with dementia, especially in advanced stages.
- Malnutrition and dehydration are common complications that can exacerbate dementia symptoms and impact overall health.
Purpose of the Study:
- To explore interventions for establishing and maintaining adequate nutritional intake in older individuals with dementia.
- To identify effective strategies and areas for further research in nutritional support for dementia patients.
Main Methods:
- A comprehensive literature review was conducted.
- Twelve relevant articles were identified and analyzed for intervention effectiveness.
Main Results:
- Most reviewed articles focused on interventions to support nutritional intake in older adults with dementia.
- While no single standardized intervention emerged, certain approaches demonstrated greater success than others.
- Key factors for success included enhanced staff vigilance regarding eating difficulties and food consumption.
Conclusions:
- Further research is needed to optimize nursing and assistant-led interventions for nutritional support in dementia care.
- Increased staff time and specialized training are essential to improve nutritional outcomes for this vulnerable population.
- Enhanced monitoring of eating behaviors and food intake is necessary for effective nutritional management.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...